Angelica Lozares
Nurse Practitioner · Edinburg, TXNPI 1245261718
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,155 of the $19,386 with a category attached, or 62.7%. 30 manufacturers reported payments, led by Abbott at 25.9% of the total. Among nurse practitioner clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 388 payments — averaging $49.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Penumbra, Inc.$3K
- Cardiovascular Systems Inc.$2K
- Stryker$2K
- E.r. Squibb & Sons, L.L.C.$1K
- Novartis$962
- plus $5K from 24 others
What the payments were for
- Travel & lodging$7,15737%
- Food & beverage$12,15563%
- Education$750%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 39 | $5,028 |
| Penumbra, Inc. | 13 | $3,024 |
| Cardiovascular Systems Inc. | 30 | $2,151 |
| Stryker | 5 | $1,635 |
| E.r. Squibb & Sons, L.L.C. | 54 | $1,168 |
| Novartis | 77 | $962 |
| Johnson & Johnson | 51 | $723 |
| Shockwave Medical, Inc | 16 | $621 |
| Cvrx, Inc. | 3 | $424 |
| Endologix LLC | 5 | $369 |
| W. L. Gore & Associates, Inc. | 5 | $363 |
| Pfizer | 26 | $331 |
| Boston Scientific | 4 | $317 |
| Amgen | 12 | $314 |
| AstraZeneca | 4 | $299 |
| Tactile Systems Technology Inc | 5 | $220 |
| Philips North America LLC | 2 | $208 |
| Bard Peripheral Vascular, Inc. | 4 | $203 |
| Merck | 10 | $182 |
| Actelion Pharmaceuticals US, Inc. | 4 | $171 |
| Abiomed | 2 | $127 |
| BD | 1 | $114 |
| Cordis US CORP. | 1 | $112 |
| Novo Nordisk | 4 | $102 |
| Organogenesis Inc. | 3 | $72 |
| Boehringer Ingelheim | 4 | $61 |
| Smith+Nephew | 1 | $31 |
| Esperion Therapeutics, Inc. | 1 | $26 |
| Urgo Medical North America, LLC | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$2,320
- Diamondback Peripheral$1,582
- FLOWTRIEVER CATHETER, S$1,497
- CT THROMBECTOMY SYSTEM KIT$1,497
- AVEIR$1,246
- HeartMate 3 Left Ventricular Assist Device$799
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$645
- RUBY Coil$547
- ELIQUIS$448
- Barostim Neo System$424
- ESPRIT$412
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$338
- GALLANT$327
- GENERAL THROMBECTOMY$257
- Torus Stent Graft System$256
- ENDOCROSS Device$256
- GORE VIABAHN Endoprosthesis with Heparin$252
- CAMZYOS$235
- CardioMEMS HF System$175
- Confirm Rx$151
How this compares
$19,386 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 91 | $133,358 |
| EliquisApixaban | 61 | $78,914 |
| EntrestoSacubitril/Valsartan | 29 | $36,414 |
| Ranolazine ErRanolazine | 41 | $5,350 |
| Metoprolol Succinate | 156 | $2,074 |
| ClopidogrelClopidogrel Bisulfate | 121 | $1,175 |
| Cilostazol | 41 | $1,120 |
| Atorvastatin Calcium | 121 | $1,053 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 98 | $993 |
| Losartan Potassium | 61 | $625 |
| Labetalol Hcl | 27 | $618 |
| Nifedipine ErNifedipine | 18 | $568 |
| Metoprolol Tartrate | 69 | $428 |
| Lisinopril | 39 | $426 |
| Nitroglycerin | 11 | $316 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $723 | $133,35891 claims |
| PfizerEliquis | $331 | $78,91461 claims |
| NovartisEntresto | $962 | $36,41429 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Edinburg
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Onna FeuchterSouthlake$108K
- Stephanie AgrellaRound Rock$102K
- Sue RankinAmarillo$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.